Athyrium Capital Management, LP — Q1 2018 13F Holdings

Name: Athyrium Capital Management, LP — 13F Holdings, Q1 2018
Creator: AlphaSMO
License: https://www.sec.gov/forms

CIK: 0001728001

Total reported value

$8.7B

Full holdings list this quarter

#	Ticker	Issuer	Asset Subclass	Weight	Weight Change	Shares Change
1	AEGR 2 08-15-19	Aegerion Pharmaceuticals	Stock-Other	45.05%	—	—
2	✓	Vivus INC	Stock-Other	27.19%	—	—
3	PTCT 3 08-15-22	Ptc Therapeutics INC	Stock-Healthcare	26.79%	—	+2.19%
4	HQ8F	Apollo Endosurgery INC	Stock-Other	0.97%	—	—

Position changes disclosed by Athyrium Capital Management, LP for the quarter ending Q1 2018, including ticker, issuer, weight change, shares change, and action
#	Ticker	Issuer	Weight Change	Shares Change	Action
1	PTCT 3 08-15-22	Ptc Therapeutics INC	+5.1%	+2.19%	Add
2	✓	Vivus INC	+4.3%	—	Unchanged
3	HQ8F	Apollo Endosurgery INC	+0.1%	—	Unchanged
4	AEGR 2 08-15-19	Aegerion Pharmaceuticals	-0.8%	—	Unchanged
5	✓	Sucampo Pharmaceuticals INC	—	EXIT	Sold out